Glad our review on Ultrasmall NPs to target tumour selected as cover (DOI: 10.1002/adtp.202300019) Credit to Lena (not on twitter) for design & excellent collaboration between detappelab.com & Tillement Group (iLM, Recherche) @alxdetappe @AdvSciNews European Research Council (ERC) -

📢 Join us for an enlightening webinar on Trained Immunity using Nanotherapeutics with Dr. Roy van der Meel and David Schrijver. 🗓️ Date: 23 October 2023 🕒 Time: 4:00 CEST 🔗 Register here: lnkd.in/eKy7bd5Y #SFNanoJR_1st_webinar SFNano

Many thanks to Dr. Roy van der Meel Roy van der Meel and David Schrijver David Schrijver for the exciting talks about the role of #nanotechnology in #immunomodulation. Looking forward to seeing your published work that was discussed today 👏👏

2ème matinée de notre 13ème Forum : une première session de communications sélectionnées, suivi par une session sur les développements technologiques en immunothérapie introduite par Hervé Watier (Tours) #Forum2023

Thank you to la Ligue CCIR Est and Cancéropôle Est for this nice forum and the poster award on our work on targeting multiple myeloma. Great teamwork between detappelab.com Alex Detappe and Loïc Charbonniere from @SynpaTeam IPHC Strasbourg #ICANS

The lab is hiring a postdoctoral fellow for our #ERCPOC project "SubNK". Feel free to contact me at [email protected] if interested. Thanks for sharing ! Cancéropôle Est European Research Council (ERC) Fondation ARC @IMStrasbourg - IPHC Strasbourg CNRS Alsace

We are still hiring. Looking for a biochemist, chemist, or biologist, with deep interest in hydrogel development and validation eager to work on cell therapies. La Ligue contre le cancer European Research Council (ERC) Cancéropôle Est #ICANS Young Scientist Committee YSC-CRS Controlled Release Society CRS Immuno Delivery CRS BeNeLux & France Local Chapter CRS Focus Group-BioEng

Such an elegant idea from the Gray lab! Target two nucleophiles simultaneously to reduce the probability of resistance mutation formation. Dielectrophiles were previously reported, but to my knowledge not in the context of avoiding resistance. Very cool. pubs.acs.org/doi/10.1021/ac…

📢 Save the date !! Join us for an enlightening webinar on PEG alternatives for Nanoparticles! 🗓️ Date: 29th of March 2024 🕒 Time: 2:00 CEST 🔗 Register here: forms.gle/aWrZUdB8z9rnyj…

First up in this session, Ryan Potts showed two nice examples of proximity induction that do not lead to degradation: a KIF18A-tubulin stabilizing molecular glue and a "LOCKTAC" that plugs up PRMT5 with MTA.

Our latest paper was selected as front cover of @AdvSciNews Advanced Healthcare Materials journal🍾🍾 Ella Marushchenko #ICANS

Proximity-inducing #molecularglues for RAS- and RAF-dependent cancers

Our latest work reviewing the landscape of subcutaneous administration of mAbs in oncology in @AdvSciNews #AdvMaterials is now published - Congrats to Guillaume et al & thanks to our funding agencies European Research Council (ERC) #FFRMG @IMStrasbourg ANR - Agence nationale de la recherche - onlinelibrary.wiley.com/doi/epdf/10.10…

ABSTRACTS SUBMITION is open now on: sfnanojr-2.sciencesconf.org We are waiting for you :) Fell free to contact us on our social media or email ([email protected]) for further inquiries !!

Out now in Nature Reviews Bioengineering EPR Effect vs. ATR Principle How do nanoparticles accumulate in tumors? Not surprisingly, the answer is “it depends”. On the intrinsic leakiness of the tumor and on the type of nanoparticle used. Check out the full comment👇 nature.com/natrevbioeng/v…

This is an interesting use of a miRNA as a protein recruiting element in a degrader to take out Lin28. Delivery challenges always the issue with this type of thing, but still pretty neat. science.org/doi/10.1126/sc…

Interested in doing a postdoc in my lab in Strasbourg or at Gustave Roussy under this program? Get in touch! Application deadline: 10.09.25. …sklodowska-curie-actions.ec.europa.eu/calls/msca-pos…